Study Summary
This trial is testing new methods of imaging transplanted lungs to see if they can detect changes early on that could lead to BOS, a chronic allograft rejection.
- Bronchiolitis Obliterans
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
0 Primary · 1 Secondary · Reporting Duration: 12 months post transplant
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
Hp 129Xenon
1 of 1
Experimental Treatment
45 Total Participants · 1 Treatment Group
Primary Treatment: Hp 129Xenon · No Placebo Group · Phase 1 & 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age Any Age · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there opportunities for enrolment in this research effort?
"Affirmative, the information found on clinicaltrials.gov implies that this experiment is actively recruiting participants. It was initially posted on September 9th 2020 and has been modified as recently as December 17th 2020. 45 individuals are needed to contribute at a single site." - Anonymous Online Contributor
How many participants are currently being analyzed as part of this research endeavor?
"Affirmative. Clinicaltrials.gov data indicate that this clinical trial is presently attempting to recruit participants, which was first posted on September 9th 2020 and last edited December 17th 2020. 45 patients are required for the study at a single site." - Anonymous Online Contributor